SHAREHOLDER ALERT: Morris Kandinov Investigating EQIX, SMVLX, SVXLX, and EXTR; Shareholders are Encouraged to Contact the Firm
15 janv. 2025 09h00 HE
|
Morris Kandinov, LLP
SHAREHOLDER ALERT: Morris Kandinov Investigating EQIX, SMVLX, SVXLX, and EXTR.
SKYX Announces that it Will Begin Supplying its Products to 140 Commercial Units in January 2025
15 janv. 2025 08h45 HE
|
SKYX Platforms Corp.
SKYX Announces that it Will Begin Supplying its Products to 140 Commercial Units in January 2025
LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million
15 janv. 2025 08h02 HE
|
LuxUrban Hotels Inc.
LuxUrban Issues Corporate update and 2025 Revenue Guidance of $62–$67 million
BranchOut Food Projects $9 Million in H1 2025 Revenue, Highlighted by $4 Million from Nation’s Largest Warehouse Club
15 janv. 2025 08h00 HE
|
BranchOut Food Inc.
BranchOut Food Projects $9 Million in H1 2025 Revenue, Highlighted by $4 Million from Nation’s Largest Warehouse Club
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
14 janv. 2025 12h29 HE
|
Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Pacira To Contact Him Directly To Discuss Their Options If...
Sezzle Unveils Money IQ: An Interactive Rewards Program Promoting Financial Education
14 janv. 2025 08h14 HE
|
Sezzle
Minneapolis, MN, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // - Sezzle, the leading Buy Now, Pay Later (BNPL) solution, is excited to announce the launch of a...
Xeriant Appoints Mark Sternberg, Successful Business Leader and Nanomaterial Applications Innovator
14 janv. 2025 08h05 HE
|
Xeriant, Inc.
Xeriant (OTCQB: XERI) appoints nano-coatings and nanomaterial expert, Mark Sternberg, to the Company’s Advisory Board
Lux Urban Hotels Embraces the Future with Digital Currency–Powered Guest Experiences
14 janv. 2025 08h00 HE
|
LuxUrban Hotels Inc.
Lux Urban Hotels Embraces the Future of Hospitality with Crypto-Powered Guest Experiences
Silexion Therapeutics to Present SIL-204 Data in KRAS-Driven Pancreatic Cancer at the 2025 ASCO Gastrointestinal Cancers Symposium
13 janv. 2025 07h50 HE
|
Silexion Therapeutics Corp
Cayman Islands, January 13, 2025 -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results
13 janv. 2025 07h00 HE
|
Sono-Tek Corporation
Sono-Tek Reports Third Quarter and Nine Months Fiscal 2025 Financial Results